Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Diagnostic Enzymes Market by Product Type (Carbohydrases, Polymerases and Nucleases, Protease, Others), by Application (Biocatalysts, Diagnostics, Pharmaceuticals, Research and Biotechnology) and by Source (Animals, Microorganisms, Plants): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03378

Pages: NA

Charts: NA

Tables: NA

Diagnostic enzymes are type of enzymes or proteins that have special properties such as high specificity, and therefore behave as a biocatalyst to accelerate the chemical reactions & produce the desired results in a biochemical reaction. Owing to low requirement and high degree of specificity, these enzymes have witnessed a growth in demand in medical fields.

Rise in geriatric population that increases the patient pool for diagnosis of chronic diseases, growth in popularity of these enzymes in detection of chronic diseases such as cardiovascular diseases, cancer, pain & inflammatory disorders, adoption of advanced enzymes such as immobilized enzymes having higher stability, and increase in healthcare expenditures drive the market. However, safety concerns due to high susceptibility of enzymes toward contamination impede the market growth. Technological advancements to produce enzymes having advanced diagnostic features and high resistance against deterioration provides broad range of opportunities for the manufacturers in this market.

The global diagnostic enzymes market is segmented on the basis of product type, application, source, and geography. On the basis of product type, it is divided into carbohydrases, polymerases & nucleases, protease, and others. Based on applications, it is classified into biocatalysts, diagnostics, pharmaceuticals, and research & biotechnology. According to source, the market is categorized into animals, microorganisms, and plants. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies profiled in this report include Spark Therapeutics, Inc., Genzyme Corporation, Aldevron, Kaneka Eurogentec S.A., Biovian, Brammer Bio, Cobra Biologics, FinVector Vision Therapies, Oxford Gene Technology, and Vigene Biosciences Inc.

Key Benefits

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market by country assists in understanding the regional trends.
  • Key players and their strategies are analyzed to understand the competitive outlook of the market.

 Key Market Segments

  • By Product Type
    • Carbohydrases
    • Polymerases and Nucleases
    • Protease
    • Others
  • By Application
    • Biocatalysts
    • Diagnostics
    • Pharmaceuticals
    • Research and Biotechnology
  • By Source
    • Animals
    • Microorganisms
    • Plants
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Aldevron
  • FinVector Vision Therapies
  • Brammer Bio
  • Kaneka Eurogentec S.A.
  • Vigene Biosciences Inc.
  • Cobra Biologics
  • Genzyme Corporation
  • Biovian
  • Spark Therapeutics, Inc.
  • Oxford Gene Technology

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: DIAGNOSTIC ENZYMES MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Carbohydrases

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Polymerases And Nucleases

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Protease

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Others

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: DIAGNOSTIC ENZYMES MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Biocatalysts

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Diagnostics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Pharmaceuticals

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Research And Biotechnology

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: DIAGNOSTIC ENZYMES MARKET, BY SOURCE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Source

    • 6.2. Animals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Microorganisms

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Plants

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: DIAGNOSTIC ENZYMES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product Type

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By Source

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Diagnostic Enzymes Market

        • 7.2.6.1. Market Size and Forecast, By Product Type
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By Source

      • 7.2.7. Canada Diagnostic Enzymes Market

        • 7.2.7.1. Market Size and Forecast, By Product Type
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By Source

      • 7.2.8. Mexico Diagnostic Enzymes Market

        • 7.2.8.1. Market Size and Forecast, By Product Type
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By Source

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product Type

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By Source

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Diagnostic Enzymes Market

        • 7.3.6.1. Market Size and Forecast, By Product Type
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By Source

      • 7.3.7. Germany Diagnostic Enzymes Market

        • 7.3.7.1. Market Size and Forecast, By Product Type
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By Source

      • 7.3.8. Italy Diagnostic Enzymes Market

        • 7.3.8.1. Market Size and Forecast, By Product Type
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By Source

      • 7.3.9. Spain Diagnostic Enzymes Market

        • 7.3.9.1. Market Size and Forecast, By Product Type
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By Source

      • 7.3.10. UK Diagnostic Enzymes Market

        • 7.3.10.1. Market Size and Forecast, By Product Type
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By Source

      • 7.3.11. Russia Diagnostic Enzymes Market

        • 7.3.11.1. Market Size and Forecast, By Product Type
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By Source

      • 7.3.12. Rest Of Europe Diagnostic Enzymes Market

        • 7.3.12.1. Market Size and Forecast, By Product Type
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By Source

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product Type

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By Source

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Diagnostic Enzymes Market

        • 7.4.6.1. Market Size and Forecast, By Product Type
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By Source

      • 7.4.7. Japan Diagnostic Enzymes Market

        • 7.4.7.1. Market Size and Forecast, By Product Type
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By Source

      • 7.4.8. India Diagnostic Enzymes Market

        • 7.4.8.1. Market Size and Forecast, By Product Type
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By Source

      • 7.4.9. South Korea Diagnostic Enzymes Market

        • 7.4.9.1. Market Size and Forecast, By Product Type
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By Source

      • 7.4.10. Australia Diagnostic Enzymes Market

        • 7.4.10.1. Market Size and Forecast, By Product Type
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By Source

      • 7.4.11. Thailand Diagnostic Enzymes Market

        • 7.4.11.1. Market Size and Forecast, By Product Type
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By Source

      • 7.4.12. Malaysia Diagnostic Enzymes Market

        • 7.4.12.1. Market Size and Forecast, By Product Type
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By Source

      • 7.4.13. Indonesia Diagnostic Enzymes Market

        • 7.4.13.1. Market Size and Forecast, By Product Type
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By Source

      • 7.4.14. Rest of Asia Pacific Diagnostic Enzymes Market

        • 7.4.14.1. Market Size and Forecast, By Product Type
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By Source

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product Type

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By Source

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Diagnostic Enzymes Market

        • 7.5.6.1. Market Size and Forecast, By Product Type
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By Source

      • 7.5.7. South Africa Diagnostic Enzymes Market

        • 7.5.7.1. Market Size and Forecast, By Product Type
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By Source

      • 7.5.8. Saudi Arabia Diagnostic Enzymes Market

        • 7.5.8.1. Market Size and Forecast, By Product Type
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By Source

      • 7.5.9. UAE Diagnostic Enzymes Market

        • 7.5.9.1. Market Size and Forecast, By Product Type
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By Source

      • 7.5.10. Argentina Diagnostic Enzymes Market

        • 7.5.10.1. Market Size and Forecast, By Product Type
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By Source

      • 7.5.11. Rest of LAMEA Diagnostic Enzymes Market

        • 7.5.11.1. Market Size and Forecast, By Product Type
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By Source

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Spark Therapeutics, Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Genzyme Corporation

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Aldevron

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Kaneka Eurogentec S.A.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Biovian

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Brammer Bio

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Cobra Biologics

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. FinVector Vision Therapies

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Oxford Gene Technology

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Vigene Biosciences Inc.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL DIAGNOSTIC ENZYMES MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR CARBOHYDRASES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR POLYMERASES AND NUCLEASES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR PROTEASE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL DIAGNOSTIC ENZYMES MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR BIOCATALYSTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR PHARMACEUTICALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR RESEARCH AND BIOTECHNOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL DIAGNOSTIC ENZYMES MARKET, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR ANIMALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR MICROORGANISMS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC ENZYMES MARKET FOR PLANTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC ENZYMES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA DIAGNOSTIC ENZYMES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 20. U.S. DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 21. U.S. DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. U.S. DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 23. CANADA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 24. CANADA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. CANADA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE DIAGNOSTIC ENZYMES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 39. ITALY DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 40. ITALY DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. ITALY DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 45. UK DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 46. UK DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. UK DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC DIAGNOSTIC ENZYMES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 58. CHINA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 59. CHINA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. CHINA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 64. INDIA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 65. INDIA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. INDIA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA DIAGNOSTIC ENZYMES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 98. UAE DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 99. UAE DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 100. UAE DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA DIAGNOSTIC ENZYMES, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA DIAGNOSTIC ENZYMES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA DIAGNOSTIC ENZYMES, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 107. SPARK THERAPEUTICS, INC.: KEY EXECUTIVES
  • TABLE 108. SPARK THERAPEUTICS, INC.: COMPANY SNAPSHOT
  • TABLE 109. SPARK THERAPEUTICS, INC.: OPERATING SEGMENTS
  • TABLE 110. SPARK THERAPEUTICS, INC.: PRODUCT PORTFOLIO
  • TABLE 111. SPARK THERAPEUTICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. GENZYME CORPORATION: KEY EXECUTIVES
  • TABLE 113. GENZYME CORPORATION: COMPANY SNAPSHOT
  • TABLE 114. GENZYME CORPORATION: OPERATING SEGMENTS
  • TABLE 115. GENZYME CORPORATION: PRODUCT PORTFOLIO
  • TABLE 116. GENZYME CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. ALDEVRON: KEY EXECUTIVES
  • TABLE 118. ALDEVRON: COMPANY SNAPSHOT
  • TABLE 119. ALDEVRON: OPERATING SEGMENTS
  • TABLE 120. ALDEVRON: PRODUCT PORTFOLIO
  • TABLE 121. ALDEVRON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. KANEKA EUROGENTEC S.A.: KEY EXECUTIVES
  • TABLE 123. KANEKA EUROGENTEC S.A.: COMPANY SNAPSHOT
  • TABLE 124. KANEKA EUROGENTEC S.A.: OPERATING SEGMENTS
  • TABLE 125. KANEKA EUROGENTEC S.A.: PRODUCT PORTFOLIO
  • TABLE 126. KANEKA EUROGENTEC S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. BIOVIAN: KEY EXECUTIVES
  • TABLE 128. BIOVIAN: COMPANY SNAPSHOT
  • TABLE 129. BIOVIAN: OPERATING SEGMENTS
  • TABLE 130. BIOVIAN: PRODUCT PORTFOLIO
  • TABLE 131. BIOVIAN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. BRAMMER BIO: KEY EXECUTIVES
  • TABLE 133. BRAMMER BIO: COMPANY SNAPSHOT
  • TABLE 134. BRAMMER BIO: OPERATING SEGMENTS
  • TABLE 135. BRAMMER BIO: PRODUCT PORTFOLIO
  • TABLE 136. BRAMMER BIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. COBRA BIOLOGICS: KEY EXECUTIVES
  • TABLE 138. COBRA BIOLOGICS: COMPANY SNAPSHOT
  • TABLE 139. COBRA BIOLOGICS: OPERATING SEGMENTS
  • TABLE 140. COBRA BIOLOGICS: PRODUCT PORTFOLIO
  • TABLE 141. COBRA BIOLOGICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. FINVECTOR VISION THERAPIES: KEY EXECUTIVES
  • TABLE 143. FINVECTOR VISION THERAPIES: COMPANY SNAPSHOT
  • TABLE 144. FINVECTOR VISION THERAPIES: OPERATING SEGMENTS
  • TABLE 145. FINVECTOR VISION THERAPIES: PRODUCT PORTFOLIO
  • TABLE 146. FINVECTOR VISION THERAPIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. OXFORD GENE TECHNOLOGY: KEY EXECUTIVES
  • TABLE 148. OXFORD GENE TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 149. OXFORD GENE TECHNOLOGY: OPERATING SEGMENTS
  • TABLE 150. OXFORD GENE TECHNOLOGY: PRODUCT PORTFOLIO
  • TABLE 151. OXFORD GENE TECHNOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. VIGENE BIOSCIENCES INC.: KEY EXECUTIVES
  • TABLE 153. VIGENE BIOSCIENCES INC.: COMPANY SNAPSHOT
  • TABLE 154. VIGENE BIOSCIENCES INC.: OPERATING SEGMENTS
  • TABLE 155. VIGENE BIOSCIENCES INC.: PRODUCT PORTFOLIO
  • TABLE 156. VIGENE BIOSCIENCES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL DIAGNOSTIC ENZYMES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL DIAGNOSTIC ENZYMES MARKET
  • FIGURE 3. SEGMENTATION DIAGNOSTIC ENZYMES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN DIAGNOSTIC ENZYMES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDIAGNOSTIC ENZYMES MARKET
  • FIGURE 11. DIAGNOSTIC ENZYMES MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. DIAGNOSTIC ENZYMES MARKET FOR CARBOHYDRASES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. DIAGNOSTIC ENZYMES MARKET FOR POLYMERASES AND NUCLEASES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. DIAGNOSTIC ENZYMES MARKET FOR PROTEASE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. DIAGNOSTIC ENZYMES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. DIAGNOSTIC ENZYMES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 17. DIAGNOSTIC ENZYMES MARKET FOR BIOCATALYSTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. DIAGNOSTIC ENZYMES MARKET FOR DIAGNOSTICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. DIAGNOSTIC ENZYMES MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. DIAGNOSTIC ENZYMES MARKET FOR RESEARCH AND BIOTECHNOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. DIAGNOSTIC ENZYMES MARKET SEGMENTATION, BY BY SOURCE
  • FIGURE 22. DIAGNOSTIC ENZYMES MARKET FOR ANIMALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. DIAGNOSTIC ENZYMES MARKET FOR MICROORGANISMS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. DIAGNOSTIC ENZYMES MARKET FOR PLANTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: DIAGNOSTIC ENZYMES MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. SPARK THERAPEUTICS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. SPARK THERAPEUTICS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. SPARK THERAPEUTICS, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. GENZYME CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. GENZYME CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. GENZYME CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. ALDEVRON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. ALDEVRON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. ALDEVRON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. KANEKA EUROGENTEC S.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. KANEKA EUROGENTEC S.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. KANEKA EUROGENTEC S.A.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. BIOVIAN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. BIOVIAN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. BIOVIAN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. BRAMMER BIO: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. BRAMMER BIO: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. BRAMMER BIO: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. COBRA BIOLOGICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. COBRA BIOLOGICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. COBRA BIOLOGICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. FINVECTOR VISION THERAPIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. FINVECTOR VISION THERAPIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. FINVECTOR VISION THERAPIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. OXFORD GENE TECHNOLOGY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. OXFORD GENE TECHNOLOGY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. OXFORD GENE TECHNOLOGY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. VIGENE BIOSCIENCES INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. VIGENE BIOSCIENCES INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. VIGENE BIOSCIENCES INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Diagnostic Enzymes Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved